姚記科技(002605.SZ):控股股東內部轉讓1.72%股份至阿巴馬28號基金
格隆匯6月30日丨姚記科技(002605.SZ)公吿,因個人資產規劃需要,控股股東、實際控制人姚文琛於2021年6月28日-6月30日通過大宗交易方式合計轉讓692.9419萬股無限售流通股給姚文琛和夢工場建輝見性私募證券投資基金(“夢工場建輝基金”)共同持有的阿巴馬悦享紅利28號私募證券投資基金(“阿巴馬28號基金”),轉讓股份佔公司股本的1.72%。
姚文琛為夢工場建輝基金的唯一所有人,且與夢工場建輝基金和阿巴馬28號基金共同簽署《一致行動人協議》,三方形成一致行動關係。本次股份變動來源為公司資本公積金轉增股本獲得的股份,不涉及向市場減持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.